TY - JOUR
T1 - Development of an Australian cardiovascular disease mortality risk score using multiple imputation and recalibration from national statistics
AU - Backholer, Kathryn
AU - Hirakawa, Yoichiro
AU - Tonkin, Andrew
AU - Giles, Graham
AU - Magliano, Dianna J.
AU - Colagiuri, Stephen
AU - Harris, Mark
AU - Mitchell, Paul
AU - Nelson, Mark
AU - Shaw, Jonathan E.
AU - Simmons, David
AU - Simons, Leon
AU - Taylor, Anne
AU - Harding, Jessica
AU - Gopinath, Bamini
AU - Woodward, Mark
N1 - Funding Information:
This work was funded by a grant (100751) from the Australian National Heart Foundation. Kathryn Backholer was supported by a National Heart Foundation of Australia Post-Doctoral Fellowship (PH 12 M6824) and Mark Woodward was supported by a National Health and Medical Research Council Principal Research Fellowship. Data from five studies - The Australian, Diabetes Obesity and Lifestyle Study, Blue Mountain Eyes Study, The Dubbo study, The Crossroads Undiagnosed Diabetes Study and the North West Adelaide Health Study – were obtained from The Australian and New Zealand Diabetes and Cancer Cohort. This was funded by a National Health and Medical Research Council grant (APP1002663). Baseline recruitment for the Melbourne Collaborative Cohort Study was funded by VicHealth and Cancer Council Victoria. Follow-up has been supported by Australian NHMRC grants 209057, 251553 and 504711 and by infrastructure provided by Cancer Council Victoria. Deaths have been ascertained through the Victorian Registrar of Births Deaths and Marriages and by record linkage to the National Death Index at the Australian Institute of Health and Welfare. Australian national data were obtained from the Australian Bureau of Statistics.
Publisher Copyright:
© 2017 The Author(s).
PY - 2017/1/6
Y1 - 2017/1/6
N2 - Objective: To develop and recalibrate an Australian 5-year cardiovascular disease (CVD) mortality risk score to produce contemporary predictions of risk. Methods: Data were pooled from six Australian cohort studies (n=54,829), with baseline data collected between 1989 and 2003. Participants included were aged 40-74 years and free of CVD at baseline. Variables were harmonised across studies and missing data were imputed using multiple imputation. Cox proportional hazards models were used to estimate the risk of CVD mortality associated with factors mutually independently predictive (p<0.05) and a 5-year risk prediction algorithm was constructed. This algorithm was recalibrated to reflect contemporary national levels of CVD mortality and risk factors using national statistics. Results: Over a mean 16.6years follow-up, 1375 participants in the six studies died from CVD. The prediction model included age, sex, smoking, diabetes, systolic blood pressure, total and high-density lipoprotein cholesterol (HDLC), a social deprivation score, estimated glomerular filtration rate and its square and interactions of sex with diabetes, HDLC and deprivation score, and of age with systolic blood pressure and smoking. This model discriminated well when applied to a Scottish study population (c-statistic (95% confidence interval): 0.751 (0.709, 0.793)). Recalibration generally increased estimated risks, but well below those predicted by the European SCORE models. Conclusions: The resulting risk score, which includes markers of both chronic kidney disease and socioeconomic deprivation, is the first CVD mortality risk prediction tool for Australia to be derived using Australian data. The primary model, and the method of recalibration, is applicable elsewhere.
AB - Objective: To develop and recalibrate an Australian 5-year cardiovascular disease (CVD) mortality risk score to produce contemporary predictions of risk. Methods: Data were pooled from six Australian cohort studies (n=54,829), with baseline data collected between 1989 and 2003. Participants included were aged 40-74 years and free of CVD at baseline. Variables were harmonised across studies and missing data were imputed using multiple imputation. Cox proportional hazards models were used to estimate the risk of CVD mortality associated with factors mutually independently predictive (p<0.05) and a 5-year risk prediction algorithm was constructed. This algorithm was recalibrated to reflect contemporary national levels of CVD mortality and risk factors using national statistics. Results: Over a mean 16.6years follow-up, 1375 participants in the six studies died from CVD. The prediction model included age, sex, smoking, diabetes, systolic blood pressure, total and high-density lipoprotein cholesterol (HDLC), a social deprivation score, estimated glomerular filtration rate and its square and interactions of sex with diabetes, HDLC and deprivation score, and of age with systolic blood pressure and smoking. This model discriminated well when applied to a Scottish study population (c-statistic (95% confidence interval): 0.751 (0.709, 0.793)). Recalibration generally increased estimated risks, but well below those predicted by the European SCORE models. Conclusions: The resulting risk score, which includes markers of both chronic kidney disease and socioeconomic deprivation, is the first CVD mortality risk prediction tool for Australia to be derived using Australian data. The primary model, and the method of recalibration, is applicable elsewhere.
UR - http://www.scopus.com/inward/record.url?scp=85008329612&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85008329612&partnerID=8YFLogxK
U2 - 10.1186/s12872-016-0462-5
DO - 10.1186/s12872-016-0462-5
M3 - Article
C2 - 28061760
AN - SCOPUS:85008329612
SN - 1471-2261
VL - 17
JO - BMC Cardiovascular Disorders
JF - BMC Cardiovascular Disorders
IS - 1
M1 - 17
ER -